Harrow, Inc. Share Price & Technical Analysis
HROW · $32.78 (-0.55%)
Healthcare / Drug Manufacturers - Specialty & Generic
$32.78
-0.55%
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, inc…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
-19% return in May, 21% avg return in past 3 year May month.
-33% return in 2026, 72% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -17% | 25% | -34% | 12% | -19% | – | – | – | – | – | – | – | -33% |
| 25 | -10% | -4% | -5% | -5% | 13% | 9% | 6% | 26% | 25% | -21% | 11% | 19% | 63% |
| 24 | -15% | 14% | 22% | -24% | 76% | 15% | 23% | 57% | 12% | 1% | -8% | -19% | 153% |
| 23 | 1% | 19% | 18% | 19% | -25% | 1% | 17% | -31% | -5% | 1% | -36% | 22% | 1% |
| 22 | -13% | 4% | -13% | 0% | 7% | 0% | -8% | 34% | 34% | -1% | -8% | 32% | 70% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE, as well as BYQLOVI; MAXITROL eye drops; ILEVRO and NEVANAC, a non-steroidal and anti-inflammatory eye drop for pain and inflammation associated with cataract surgery; BYOOVIZ, a LUCENTIS biosimilar indicated for the treatment of patients with Neovascular (Wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), and myopic choroidal neovascularization (mCNV); VIGAMOX, a fluoroquinolone antibiotic eye drop for the treatment of bacterial conjunctivitis; OPUVIZ, an EYLEA biosimilar indicated for the treatment of patients with Wet AMD, macular edema following RVO, diabetic macular edema (DME), and diabetic retinopathy (DR); MAXIDEX and FLAREX, a steroid eye drop for steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe and the eye; TRIESENCE, a steroid injection for the treatment of ophthalmic diseases and for visualization during vitrectomy; and NATACYN, a sterile, antifungal drug for the treatment of fungal blepharitis, conjunctivitis, and keratitis. In addition, it offers TOBRADEX ST, a tobramycin and dexamethasone ophthalmic suspension; VERKAZIA cyclosporine ophthalmic emulsion; NEVANAC, a non-steroidal, anti-inflammatory eye drop; and FRESHKOTE preservative free (PF) is a lubricant eye drop. The company was formerly known as Harrow Health, Inc. and changed its name to Harrow, Inc. in September 2023. Harrow, Inc. was founded in 1998 and is headquartered in Nashville, Tennessee.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.10B
P/E ratio
—
52W high
$54.85
52W low
$25.21
Volume
81,520
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Harrow, Inc. share price today?
- Harrow, Inc. (HROW) last traded around $32.78 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does HROW have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for HROW. Download the app for real-time alerts.
- How can I analyze Harrow, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.